Mirion Technologies MIR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical Segment | $314.3M+4.2% | $310.8M+3.7% | $313.9M+6.3% | $309.5M+6.7% | $301.5M+5.8% | |
| Nuclear & Safety | $666.7M+17.2% | $614.6M+9.5% | $588.4M+12.8% | $576.5M+11.3% | $568.7M+10.8% | |
| Segment Income From Operations by Business | ||||||
| Medical Segment | $48M+73.9% | $46.9M+110% | $40.2M+195% | $33.5M+160% | $27.6M+148% | |
| Nuclear & Safety | $100.3M+14.0% | $101.1M+28.1% | $95.1M+66.0% | $88.5M+63.6% | $88M+86.8% | |
| Adjusted Income Loss From Operations by Business | ||||||
| Medical Segment | -$109.9M-2.0% | -$109M-0.3% | -$112M-6.2% | -$111.1M-5.5% | -$107.7M-1.6% | |
| Nuclear & Safety | -$354.3M-17.4% | -$324M-7.9% | -$313.5M-10.7% | -$308.7M-8.9% | -$301.7M-5.8% | |
| Other segment items by Business | ||||||
| Medical Segment | $156.4M-5.9% | $154.9M-8.2% | $161.7M-2.7% | $164.9M+0.5% | $166.2M+1.9% | |
| Nuclear & Safety | $212.1M+18.5% | $189.5M+4.2% | $179.8M-0.6% | $179.3M-0.6% | $179M-1.1% | |
| D&A by Business | ||||||
| Medical Segment | $65.3M-7.9% | $65.5M-10.3% | $66.6M-10.6% | $68.6M-8.2% | $70.9M-5.3% | |
| Nuclear & Safety | $79M+7.3% | $71.7M-6.5% | $69.4M-14.8% | $71.1M-14.7% | $73.6M-13.7% | |
| CapEx by Business | ||||||
| Medical Segment | $19.2M-20.3% | $20.2M-27.9% | $19.5M-30.2% | $21.1M-19.8% | $24.1M-3.4% | |
| Nuclear & Safety | $20M+14.3% | $18.7M+5.6% | $19.8M+26.1% | $18.4M+10.8% | $17.5M+1.7% | |
| Translation adjustment by Business | ||||||
| Medical Segment | $0— | $0— | $0— | $0— | $0— | |
| Nuclear & Safety | $23.8M+868% | $46.8M+313% | $39.3M+387% | $33.5M+726% | -$3.1M-204% | |
| Goodwill by Business | ||||||
| Medical Segment | $2.54B— | $2.54B— | $2.54B— | —— | —— | |
| Nuclear & Safety | $3.36B— | $2.94B— | $2.49B— | —— | —— | |
| Total revenues by Product | ||||||
| Cancer care | $243.4M+5.8% | $239.1M+4.9% | $241.2M+11.7% | $236.3M+11.0% | $230.1M+9.1% | |
| Labs and research | $123.7M-1.4% | $122.2M-7.2% | $124.8M-0.8% | $126.2M+4.2% | $125.5M+0.3% | |
| Other | $112.2M+2.8% | $113M+0.2% | $112.9M+8.6% | $110.1M+6.5% | $109.1M+11.8% | |
| Total cost of revenues by Product | ||||||
| Product | $407.8M+16.1% | $376.6M+8.0% | $365.6M+6.5% | $361.9M+5.7% | $351.4M+2.8% | |
| Service | $111.6M+1.4% | $110.2M-2.0% | $111.3M+3.3% | $110.3M+4.8% | $110.1M+4.8% | |
| Total revenues by Geography | ||||||
| Asia Pacific | $14.5M+12.4% | $15.6M+20.9% | $14.2M-7.8% | $13.9M-3.5% | $12.9M-13.4% | |
| Europe | $340.1M+12.1% | $327.7M+7.2% | $318.5M+7.3% | $308.1M+6.6% | $303.4M+7.9% | |
| North America | $626.4M+13.1% | $582.1M+7.4% | $569.6M+8.6% | $564M+8.9% | $553.9M+7.5% | |
| Property, plant, and equipment, net by Geography | ||||||
| Asia Pacific | $400K— | $400K— | $400K— | —— | —— | |
| Europe | $241.9M— | $239.6M— | $232.9M— | —— | —— | |
| North America | $371.6M— | $369.5M— | $367.6M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Mirion Technologies break its business down?
- Mirion Technologies (MIR) reports total revenues by business across 2 parts — Medical Segment and Nuclear & Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Mirion Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mirion Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.